Concepedia

Author

Aneta Aleksova

University of TriesteORCID

Also Known As

A ALEKSOVA, A ALEKSOVAAUAPIVETTA, A Aleksova, A. Aleksova, Aleksova Aneta, Aneta Aleksova, on the behalf of the CandHeart Investigators

133

Publications

1.7K

Citations

24

H-Index

50

Concepts

All Affiliations

University of TriesteAzienda Sanitaria Universitaria Integrata di TriesteUniversity of UdineUniversity of MilanMario Negri Institute for Pharmacological Research
AA

About

Aneta Aleksova is an author at University of Trieste specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

453

2

Public Health

3

3

80

3

Engineering

1

1

28

4

Health Sciences

1

1

23

5

Biomedical Engineering

1

1

28

Aneta Aleksova

×

30

Publications

1K

Citations

21

H-Index

YearCitations

Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial

Daniela Cardinale, Fabio Ciceri, Roberto Latini,

European Journal of Cancer

2018

224

New-onset left bundle branch block independently predicts long-term mortality in patients with idiopathic dilated cardiomyopathy: data from the Trieste Heart Muscle Disease Registry

Aneta Aleksova, Cosimo Carriere, Massimo Zecchin,

EP Europace

2014

63

Vitamin D Deficiency in Patients with Acute Myocardial Infarction: An Italian Single-Center Study

Aneta Aleksova, Rita Belfiore, Cosimo Carriere,

International Journal for Vitamin and Nutrition Research

2015

51

Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure – a subgroup analysis from the Trieste Cardiomyopathy Registry

Aneta Aleksova, Gastone Sabbadini, Marco Merlo,

Journal of Cardiovascular Medicine

2009

45

Autophagy and Inflammasome Activation in Dilated Cardiomyopathy

Angela Caragnano, Aneta Aleksova, Michela Bulfoni,

Journal of Clinical Medicine

2019

43

Atrial fibrillation in dilated cardiomyopathy: Outcome prediction from an observational registry

Vincenzo Nuzzi, Antonio Cannatà, Paolo Manca,

International Journal of Cardiology

2020

43

<i>n</i> -3 Polyunsaturated Fatty Acids and Atrial Fibrillation in Patients with Chronic Heart Failure: the GISSI-HF Trial

Aneta Aleksova, Serge Masson, Aldo P. Maggioni,

European Journal of Heart Failure

2013

42

Relation between the plasma levels of LDL-cholesterol and the expression of the early marker of inflammation long pentraxin PTX3 and the stress response gene p66(ShcA) in pacemaker-implanted patients

Alessandra Bosutti, Gabriele Grassi, Michela Zanetti,

Clinical and Experimental Medicine

2007

41

Predicting atrial fibrillation recurrence with circulating inflammatory markers in patients in sinus rhythm at high risk for atrial fibrillation: data from the GISSI atrial fibrillation trial

Serge Masson, Aneta Aleksova, C. Favero,

Heart

2010

36

Impact of Atrial Fibrillation on Outcome of Patients with Idiopathic Dilated Cardiomyopathy: Data from the Heart Muscle Disease Registry of Trieste

Aneta Aleksova, Marco Merlo, Massimo Zecchin,

Clinical Medicine & Research

2010

33

Page 1